Recurrence of spontaneous bacterial peritonitis in cirrhotic patients non-prophylactically treated with norfloxacin: Serum albumin as an easy but reliable predictive factor

Liver International

Volumn 31, Issue 2, 2011, Pages 184-191

  Huang, Chien Hao ^a   Lin, Chun Yen ^a   Sheen, I Shyan ^a   Chen, Wei Ting ^a   Lin, Tsung Nan ^a   Ho, Yu Pin ^a   Chiu, Cheng Tang ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Cirrhosis; Long term outcome; Mortality; Recurrence; Serum albumin; Spontaneous bacterial peritontitis

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CEFTRIAXONE; NORFLOXACIN; SERUM ALBUMIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL PERITONITIS; CAUSE OF DEATH; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE MARKER; FEMALE; HOSPITAL DISCHARGE; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PORTAL HYPERTENSION; PREDICTIVE VALUE; PROGNOSIS; RECURRENT DISEASE; RELIABILITY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEPSIS; SPONTANEOUS BACTERIAL PERITONITIS; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; HUMANS; LIVER CIRRHOSIS; LOGISTIC MODELS; MALE; MIDDLE AGED; NORFLOXACIN; PERITONITIS; PREDICTIVE VALUE OF TESTS; RECURRENCE; RETROSPECTIVE STUDIES; ROC CURVE; SERUM ALBUMIN; TAIWAN;

EID: 78650771842     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2010.02377.x     Document Type: Article

References (32)

1. Lin CY, Tsai IF, Ho YP, et al. Endotoxemia contributes to the immune paralysis in patients with cirrhosis. J Hepatol 2007; 46: 816-26.
2. Titó L, Rimola A, Ginès P, et al. Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. Hepatology 1988; 8: 27-31.
3. Ginés P, Rimola A, Planas R, et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology 1990; 12: 716-24.
4. Soriano G, Guarner C, Teixidó M, et al. Selective intestinal decontamination prevents spontaneous bacterial peritonitis. Gastroenterology 1991; 100: 477-81.
5. Soriano G, Guarner C, Tomás A, et al. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. Gastroenterology 1992; 103: 1267-72.
6. Saab S, Hernandez JC, Chi AC, Tong MJ. Oral antibiotic prophylaxis reduces spontaneous bacterial peritonitis occurrence and improves short-term survival in cirrhosis: a meta-analysis. Am J Gastroenterol 2009; 104: 993-1001.
7. Fernández J, Navasa M, Planas R, et al. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology 2007; 133: 818-24.
8. Rimola A, Garcia-Tsao G, Navasa M, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document international ascites club. J Hepatol 2000; 32: 142-53.
9. Pinzello G, Simonetti RG, Craxi A, et al. Spontaneous bacterial peritonitis: a prospective investigation in predominantly nonalcoholic cirrhotic patients. Hepatology 1983; 3: 545-9.
10. Runyon BA. Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis. Gastroenterology 1986; 91: 1343-6.
11. Thuluvath PJ, Morss S, Thompson R. Spontaneous bacterial peritonitis - in-hospital mortality, predictors of survival, and health care costs from 1988 to 1998. Am J Gastroenterol 2001; 96: 1232-6.
12. Song JY, Jung SJ, Park CW, et al. Prognostic significance of infection acquisition sites in spontaneous bacterial peritonitis: nosocomial versus community acquired. J Korean Med Sci 2006; 21: 666-71.
13. Toledo C, Salmerón JM, Rimola A, et al. Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime. Hepatology 1993; 17: 251-7.
14. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-70.
15. Avolio AW, Agnes S, Gasbarrini A, et al. Allocation of nonstandard livers to transplant candidates with high MELD scores: should this practice be continued? Transplant Proc 2006; 38: 3567-71.
16. Nobre SR, Cabral JE, Gomes JJ, Leitão MC. In-hospital mortality in spontaneous bacterial peritonitis: a new predictive model. Eur J Gastroenterol Hepatol 2008; 20: 1176-81.
17. Sandhu BS, Gupta R, Sharma J, et al. Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites. J Gastroenterol Hepatol 2005; 20: 599-605.
18. Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial 2004; 17: 432-7.
19. Such J, Runyon BA. Spontaneous bacterial peritonitis. Clin Infect Dis 1998; 27: 669-76.
20. Balthazar EJ, Gade MF. Gastrointestinal edema in cirrhotics. Radiographic manifestations and pathogenesis with emphasis on colonic involvement. Gastrointest Radiol 1976; 1: 215-23.
21. Hwang TL, Lue MC, Nee YJ, et al. The incidence of diarrhea in patients with hypoalbuminemia due to acute or chronic malnutrition during enteral feeding. Am J Gastroenterol 1994; 89: 376-8.
22. Sun Z, Wang X, Andersson R. Role of intestinal permeability in monitoring mucosal barrier function. History, methodology, and significance of pathophysiology. Dig Surg 1998; 15: 386-97.
23. Garcia-Tsao G. Spontaneous bacterial peritonitis. Gastroenterol Clin North Am 1992; 21: 257-75.
24. Ozturk S, Soyluk O, Karakaya D, et al. Is decline in serum albumin an ominous sign for subsequent peritonitis in peritoneal dialysis patients? Adv Perit Dial 2009; 25: 172-7.
25. Casafont F, Sánchez E, Martín L, et al. Influence of malnutrition on the prevalence of bacterial translocation and spontaneous bacterial peritonitis in experimental cirrhosis in rats. Hepatology 1997; 25: 1334-7.
26. Russell MK, McAdams MP. Laboratory monitoring of nutritional status. In: Matarese LE, Gottschlich MM., eds. Contemporary Nutrition Support Practice: A Clinical Guide. Philadelphia: W. B. Saunders, 1998; 47-63.
27. Vanek VW. The use of serum albumin as a prognostic or nutritional marker and the pros and cons of IV albumin therapy. Nutr Clin Pract 1998; 13: 110-22.
28. Sort P, Navasa M, Arroyo V, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999; 341: 403-9.
29. Scharschmidt BF. Human liver transplantation: analysis of data on 540 patients from four centers. Hepatology 1984; 4: 95S-101S.
30. Senzolo M, Cholongitas E, Burra P, et al. Beta-bockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis. Liver Int 2009; 29: 1189-93.
31. al Amri SM, Allam AR, al Mofleh IA. Spontaneous bacterial peritonitis and culture negative neutrocytic ascites in patients with non-alcoholic liver cirrhosis. J Gastroenterol Hepatol 1994; 9: 433-6.
32. Runyon BA. A pill a day can improve survival in patients with advanced cirrhosis. Gastroenterology 2007; 133: 1029-31.